Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach

British Journal of Pharmacology
B GretzerB M Peskar

Abstract

1. The effects of the non-selective cyclo-oxygenase (COX) inhibitor indomethacin and the selective COX-2 inhibitors, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398), 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-indan one (L-745,337) and 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl) phenyl-2(5H)-furanone (DFU), on the protection induced by the mild irritant 20% ethanol were investigated in the rat stomach. 2. Instillation of 20% ethanol (1 ml, p.o.) effectively protected against gastric mucosal injury induced by subsequent instillation of 70% or 96% ethanol (1 ml, p.o.). 3. Oral administration of indomethacin (1.25-20 mg kg[-1]) dose-dependently counteracted the protective effect of 20% ethanol (ID50: 3.5 mg kg[-1]). 4. Likewise, NS-398 (0.1-1 mg kg[-1]), L-745,337 (0.2-2 mg kg[-1]) and DFU (0.02-0.2 mg kg[-1]) inhibited the protective effect of 20% ethanol in a dose-dependent manner with ID50 values of 0.3 mg kg(-1), 0.4 mg kg(-1) and 0.06 mg kg(-1), respectively. 5. Inhibition of mild irritant-induced protection was also found when NS-398 (1 mg kg[-1]) was administered s.c. or when 96% ethanol was used to damage the mucosa. 6. Pretreatment with 16,16-dimethyl-prostaglandin (PG)E2 at 4 ng kg(-1),...Continue Reading

References

Jan 1, 1979·Gut·T A Miller, E D Jacobson
Jun 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·M K O'BanionD A Young
Jan 1, 1991·Pharmacology & Therapeutics·W L SmithD L DeWitt
Nov 9, 1995·Biochemical Pharmacology·J A MitchellT J Williams
Jan 1, 1995·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·J R Vane, R M Botting
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·J L MasferrerK Seibert
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J A MitchellJ R Vane
Sep 13, 1993·FEBS Letters·G P O'Neill, A W Ford-Hutchinson
Apr 1, 1996·Gastroenterology·R N DuBoisA J Entingh

❮ Previous
Next ❯

Citations

Apr 15, 2006·Digestive Diseases and Sciences·Sonlee D WestDavid W Mercer
Apr 30, 2004·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·G CoppelliG Coruzzi
Jan 5, 2002·European Journal of Pharmacology·Brigitta M PeskarBernhard A Peskar
Jul 11, 2002·European Journal of Pharmacology·Rainer Amann, Bernhard A Peskar
Jun 27, 2000·Prostaglandins & Other Lipid Mediators·S AtayA Dubois
Aug 11, 2000·Prostaglandins & Other Lipid Mediators·P R Colville-Nash, D W Gilroy
Apr 2, 1999·Trends in Pharmacological Sciences·J L Wallace
Jan 5, 2002·Gastroenterology Clinics of North America·J L Wallace
Oct 12, 2001·Journal of Physiology, Paris·B M Peskar
Oct 12, 2001·Journal of Physiology, Paris·K D Rainsford
Mar 20, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Omar M E Abdel-SalamMahmoud S Arbid
Feb 6, 2002·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·J L Wallace, M N Muscará
Dec 10, 1999·British Journal of Pharmacology·N MaricicB M Peskar
Dec 14, 1999·Alimentary Pharmacology & Therapeutics·J L WallaceM A Blank
Mar 24, 2004·Inflammopharmacology·C M Hotz-BehofsitsI T Bjarnason
Nov 2, 2005·Inflammopharmacology·Brigitta M Peskar
Jul 5, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·P R Colville-Nash, D W Gilroy
Mar 4, 2014·World Journal of Gastroenterology : WJG·Jing-Yao ZhangChang Liu
Jul 10, 2010·International Journal of Medical Sciences·Ibrahim A AlsarraSteven H Neau
Sep 17, 2002·Proceedings of the National Academy of Sciences of the United States of America·Li MaJohn L Wallace
Jan 4, 2012·Fundamental & Clinical Pharmacology·Andrelina N Coelho-de-SouzaJosé H Leal-Cardoso
Dec 20, 2005·The Journal of Surgical Research·Emily K RobinsonDavid W Mercer
Jul 3, 1998·Gastroenterology·N D YeomansA S Giraud
Sep 22, 2001·Best Practice & Research. Clinical Gastroenterology·J L Wallace
Mar 10, 2001·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·K Takeuchi, A Tanaka
Sep 21, 2005·Scandinavian Journal of Gastroenterology·Tetsuro HiratsukaChoitsu Sakamoto
Nov 15, 2013·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Se Eun LeeUy Dong Sohn
Sep 26, 2012·The Journal of Pharmacology and Experimental Therapeutics·Hiroshi SatohKoji Takeuchi
Oct 22, 2003·The Journal of Pharmacology and Experimental Therapeutics·Karlheinz EhrlichBrigitta M Peskar
Mar 11, 2003·The Journal of Pharmacology and Experimental Therapeutics·Brigitta M PeskarBernhard A Peskar
May 23, 2002·The Journal of Pharmacology and Experimental Therapeutics·Brigitta M PeskarBernhard A Peskar
Jun 23, 2000·The Journal of Pharmacy and Pharmacology·A K SinglaA Singh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.